top of page

RUNX1 Research Program

Founded in early 2016, the RUNX1 Research Program (RRP) is a research and advocacy venture committed to funding world-class, innovative and cross-disciplinary cancer research to find a cure for those individuals born with a RUNX1 mutation. They have made it their goal to support, inform, educate and connect patients and healthcare providers in the RUNX1 Community.

For more information, visit:


Disclaimer: The information contained in this page is provided by the partnering patient organization for informational purposes only.  The 40 Percent Inc. does not warrant its completeness or accuracy, and it should not be construed as an endorsement by The 40 Percent Inc. or relied upon as a basis for your support for the partnering patient organization.  The information is subject to change without notice.

bottom of page